Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 15/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.63 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27512005 | 0.90 | OPRD1 (0.82) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27501405 | 0.89 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27476085 | 0.89 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27485227 | 0.89 | OPRD1 (0.79) | OPRD1OPRM1OPRK1HPGD | |
| SCHEMBL27551286 | 0.88 | OPRD1 (0.78) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27458260 | 0.88 | OPRD1 (0.78) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27459846 | 0.88 | OPRD1 (0.78) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27457791 | 0.86 | OPRD1 (0.76) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27474131 | 0.86 | OPRD1 (0.75) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27472898 | 0.85 | OPRD1 (0.74) | OPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1408037-A1 | Novel diarylmethylpiperazine and diarylmethylphenyl compounds with analgesic effect | AstraZeneca AB (SE) | 2004-04-14 | — | — | EP | claimed |
| JP-2000502679-A | — | — | 2000-03-07 | — | — | JP | claimed |
| EP-0915855-A1 | NOVEL COMPOUNDS WITH ANALGESIC EFFECT | Astra Pharma Inc. (CA) | 1999-05-19 | — | — | EP | claimed |
| WO-1997023466-A1 | NOVEL COMPOUNDS WITH ANALGESIC EFFECT | ASTRA PHARMA INC. (CA) | 1997-07-03 | — | — | WO | claimed |
| CN-100519528-C | Compounds with analgesic effect | ASTRA PHARMACEUTICALS INC (CA) | 2009-07-29 | — | — | CN | disclosed |
| CN-1524852-A | Novel compounds with analgesic effect | ������ҩ������˾ | 2004-09-01 | — | — | CN | disclosed |
| US-20040138228-A1 | Novel compounds with analgesic effect | ASTRAZENECA CANADA INC. | 2004-07-15 | — | — | US | disclosed |
| CN-1146540-C | Novel compound with analgesic effect and application thereof | ������ҩ������˾ | 2004-04-21 | — | — | CN | disclosed |
| EP-1408037-A1 | Novel diarylmethylpiperazine and diarylmethylphenyl compounds with analgesic effect | AstraZeneca AB (SE) | 2004-04-14 | — | — | EP | disclosed |
| US-6680321-B1 | 4-((1-PIPERAZINYLMETHYL)-BENZAMIDE DERIVATIVES; HYPOTENSIVE AGENTS; IMMUNOMODULATORS | ASTRAZENECA CANADA, INC. (CA) | 2004-01-20 | — | — | US | disclosed |
| US-6130222-A | Compounds with analgesic effect | ASTRA PHARMA INC. (CA) | 2000-10-10 | — | — | US | disclosed |
| CN-1246111-A | Novel compound with analgesic effect | ASTRA PHARMA INC (CA) | 2000-03-01 | — | — | CN | disclosed |
| EP-0915855-A1 | NOVEL COMPOUNDS WITH ANALGESIC EFFECT | Astra Pharma Inc. (CA) | 1999-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138228-A1 | Novel compounds with analgesic effect | OPRL1, OPRK1, OPRM1 | OPRD1 4/4885OPRM1 3/4885OPRK1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.